250 related articles for article (PubMed ID: 15063407)
1. Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Upadya S; Lee FA; Saldarriaga C; Verma S; Sedrakyan A; Nystrom K; Katz SD
J Heart Lung Transplant; 2004 Apr; 23(4):466-72. PubMed ID: 15063407
[TBL] [Abstract][Full Text] [Related]
2. Home inotropic therapy in children.
Berg AM; Snell L; Mahle WT
J Heart Lung Transplant; 2007 May; 26(5):453-7. PubMed ID: 17449413
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home.
Brozena SC; Twomey C; Goldberg LR; Desai SS; Drachman B; Kao A; Popjes E; Zimmer R; Jessup M
J Heart Lung Transplant; 2004 Sep; 23(9):1082-6. PubMed ID: 15454175
[TBL] [Abstract][Full Text] [Related]
4. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS
Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447
[TBL] [Abstract][Full Text] [Related]
5. [Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Brügemann J; de Jonge-Weber AT; Rienstra M; van den Broek SA; Zijlstra F; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2460-5. PubMed ID: 18064867
[TBL] [Abstract][Full Text] [Related]
6. Outpatient inotropic therapy in heart transplant candidates: should its use influence waiting list priority status?
Winkel E; Kao W; Fisher SG; Heroux AL; Johnson MR; Costanzo MR
J Heart Lung Transplant; 1998 Aug; 17(8):809-16. PubMed ID: 9730431
[TBL] [Abstract][Full Text] [Related]
7. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Gorodeski EZ; Chu EC; Reese JR; Shishehbor MH; Hsich E; Starling RC
Circ Heart Fail; 2009 Jul; 2(4):320-4. PubMed ID: 19808355
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
[TBL] [Abstract][Full Text] [Related]
9. Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Drakos SG; Kanakakis JV; Nanas S; Bonios M; Kaldara E; Katsaros F; Pantsios C; Nanas JN
J Cardiovasc Pharmacol; 2009 Feb; 53(2):157-61. PubMed ID: 19188832
[TBL] [Abstract][Full Text] [Related]
10. Improved survival of patients with end-stage heart failure listed for heart transplantation: analysis of organ procurement and transplantation network/U.S. United Network of Organ Sharing data, 1990 to 2005.
Lietz K; Miller LW
J Am Coll Cardiol; 2007 Sep; 50(13):1282-90. PubMed ID: 17888847
[TBL] [Abstract][Full Text] [Related]
11. Home intravenous dobutamine therapy in patients awaiting heart transplantation.
Collins JA; Skidmore MA; Melvin DB; Engel PJ
J Heart Transplant; 1990; 9(3 Pt 1):205-8. PubMed ID: 2355273
[TBL] [Abstract][Full Text] [Related]
12. Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Mehra MR; McCluskey T; Barr M; Bourge RC; Jessup ML; Mancini D; Radovancevic B; Rayburn B; Taylor DO; Lilly-Hersley J; Linde P
Am Heart J; 2007 Jun; 153(6):932-40. PubMed ID: 17540193
[TBL] [Abstract][Full Text] [Related]
13. The use of continuous milrinone therapy as bridge to transplant is safe in patients with short waiting times.
Assad-Kottner C; Chen D; Jahanyar J; Cordova F; Summers N; Loebe M; Merla R; Youker K; Torre-Amione G
J Card Fail; 2008 Dec; 14(10):839-43. PubMed ID: 19041047
[TBL] [Abstract][Full Text] [Related]
14. [Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
Ypenburg C; Verwey HF; van der Wall EE
Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2426-8. PubMed ID: 18064859
[TBL] [Abstract][Full Text] [Related]
15. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Kurien S; Warfield KT; Wood CM; Miller WL
Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
[TBL] [Abstract][Full Text] [Related]
16. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
[TBL] [Abstract][Full Text] [Related]
17. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Meissner A; Schmelzle T; Simon R
Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
[TBL] [Abstract][Full Text] [Related]
18. Comparative costs of home positive inotropic infusion versus in-hospital care in patients awaiting cardiac transplantation.
Upadya SP; Sedrakyan A; Saldarriaga C; Nystrom K; Bozzo J; Lee FA; Katz SD
J Card Fail; 2004 Oct; 10(5):384-9. PubMed ID: 15470648
[TBL] [Abstract][Full Text] [Related]
19. Should stable UNOS Status 2 patients be transplanted?
Jimenez J; Bennett Edwards L; Higgins R; Bauerlein J; Pham S; Mallon S
J Heart Lung Transplant; 2005 Feb; 24(2):178-83. PubMed ID: 15701434
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
Baruch L; Patacsil P; Hameed A; Pina I; Loh E
Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
